Residues on Both Faces of the First Immunoglobulin Fold Contribute to Homophilic Binding Sites of PECAM-1/CD31*

CD31 (PECAM-1) is a member of the immunoglobulin superfamily whose extracellular domain is comprised of six immunoglobulin-like domains. It is widely expressed on endothelium, platelets, around 50% of lymphocytes, and cells of myeloid lineage. CD31 has been shown to be involved in interendothelial adhesion and leukocyte-endothelial interactions, particularly during transmigration. CD31-mediated adhesion is complex, because CD31 is capable of mediating both homophilic and multiple heterophilic adhesive interactions. Here we show that the NH2-terminal (membrane-distal) immunoglobulin domain of CD31 is necessary but not sufficient to support stable homophilic adhesion. Key residues forming the binding site within this domain have been identified by analysis of 26 single point mutations, representing the most systematic analysis of a fully homophilic interaction between immunoglobulin superfamily family members to date. This revealed five mutations that affect homophilic binding. Uniquely, the residues involved are exposed on both faces of the immunoglobulin fold, leading us to propose a novel mechanism for CD31 homophilic adhesion.

[1]  P. Sonderegger,et al.  Cell adhesion molecules NgCAM and axonin-1 form heterodimers in the neuronal membrane and cooperate in neurite outgrowth promotion , 1996, The Journal of cell biology.

[2]  B. Gumbiner,et al.  Lateral dimerization is required for the homophilic binding activity of C-cadherin , 1996, The Journal of cell biology.

[3]  H. DeLisser,et al.  Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Homophilic Adhesion Is Mediated by Immunoglobulin-like Domains 1 and 2 and Depends on the Cytoplasmic Domain and the Level of Surface Expression* , 1996, The Journal of Biological Chemistry.

[4]  E. Dejana,et al.  Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. , 1996, Journal of immunology.

[5]  M. Humphries,et al.  Integrin adhesion receptors: structure, function and implications for biomedicine. , 1996, Molecular medicine today.

[6]  W. Knapp,et al.  Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses , 1996, The Journal of experimental medicine.

[7]  S. Nourshargh,et al.  An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane , 1996, The Journal of experimental medicine.

[8]  P. Maurel,et al.  TAG-1/Axonin-1 Is a High-affinity Ligand of Neurocan, Phosphacan/Protein-tyrosine Phosphatase-ζ/β, and N-CAM* , 1996, The Journal of Biological Chemistry.

[9]  H. DeLisser,et al.  Individually Distinct Ig Homology Domains in PECAM-1 Regulate Homophilic Binding and Modulate Receptor Affinity (*) , 1996, The Journal of Biological Chemistry.

[10]  A. M. Lefer,et al.  Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. , 1996, Journal of immunology.

[11]  G. Edelman,et al.  Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Brown,et al.  Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1 , 1996 .

[13]  P. A. van der Merwe,et al.  The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site , 1995, The Journal of Biological Chemistry.

[14]  F. Liao,et al.  Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1 , 1995, The Journal of experimental medicine.

[15]  Michael Loran Dustin,et al.  Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1 , 1995, The Journal of experimental medicine.

[16]  H. DeLisser,et al.  Alternative Splicing of a Specific Cytoplasmic Exon Alters the Binding Characteristics of Murine Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1) (*) , 1995, The Journal of Biological Chemistry.

[17]  C. Uherek,et al.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium , 1995, The Journal of cell biology.

[18]  Peter D. Kwong,et al.  Structural basis of cell-cell adhesion by cadherins , 1995, Nature.

[19]  A. Harris,et al.  Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts , 1995, The Journal of cell biology.

[20]  E. Butcher,et al.  Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. , 1995, Blood.

[21]  D. I. Stuart,et al.  Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution , 1995, Nature.

[22]  C. Buckley,et al.  Epitope mapping and functional properties of anti‐intercellular adhesion molecule‐3 (CD50) monoclonal antibodies , 1995, European journal of immunology.

[23]  P. Anton van der Merwe,et al.  Topology of the CD2–CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells , 1995, Current Biology.

[24]  P. Bates,et al.  Analysis of the Binding Site on Intercellular Adhesion Molecule 3 for the Leukocyte Integrin Lymphocyte Function-associated Antigen 1 (*) , 1995, The Journal of Biological Chemistry.

[25]  M. Eisenstein,et al.  The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction , 1995, Cell.

[26]  H. DeLisser,et al.  Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping. , 1995, Cell adhesion and communication.

[27]  N. Kirschbaum,et al.  Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. , 1994, Blood.

[28]  C. Mickanin,et al.  Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. , 1994, Development.

[29]  R. Stevenson,et al.  X–linked spastic paraplegia (SPG1), MASA syndrome and X–linked hydrocephalus result from mutations in the L1 gene , 1994, Nature Genetics.

[30]  J. Fawcett,et al.  CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant. , 1994, Blood.

[31]  H. DeLisser,et al.  Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. , 1994, The Journal of biological chemistry.

[32]  L. Presta,et al.  Structural requirements for adhesion of soluble recombinant murine vascular cell adhesion molecule-1 to alpha 4 beta 1 , 1994, The Journal of cell biology.

[33]  S. Thom,et al.  Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. , 1993, Science.

[34]  S. Albelda,et al.  Murine platelet endothelial cell adhesion molecule (PECAM‐1)/CD31 modulates β2 integrins on lymphokine‐activated killer cells , 1993, European journal of immunology.

[35]  Y. Rao,et al.  Structural characterization of a homophilic binding site in the neural cell adhesion molecule. , 1993, The Journal of biological chemistry.

[36]  G. Alcaraz,et al.  Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds , 1993, The Journal of cell biology.

[37]  D. Phillips,et al.  PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.

[38]  H. DeLisser,et al.  Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. , 1993, The Journal of biological chemistry.

[39]  P. Sonderegger,et al.  Cell-cell adhesion by homophilic interaction of the neuronal recognition molecule axonin-1. , 1993, European journal of biochemistry.

[40]  R. Poljak,et al.  The basics of binding: mechanisms of antigen recognition and mimicry by antibodies. , 1993, Current opinion in immunology.

[41]  D. Hartley Cellular interactions in development : a practical approach , 1993 .

[42]  D. Mason,et al.  Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes , 1992, Nature.

[43]  Y. Tanaka,et al.  CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion , 1992, The Journal of experimental medicine.

[44]  H. DeLisser,et al.  A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31) , 1992, The Journal of experimental medicine.

[45]  G. Evan,et al.  Synthesis of peptides for use as immunogens. , 1992, Methods in molecular biology.

[46]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[47]  O. Majdic,et al.  Molecular characterization and functional analysis of the leukocyte surface protein CD31. , 1990, Journal of immunology.

[48]  C. Power,et al.  Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen , 1990, The Journal of experimental medicine.

[49]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[50]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[51]  R. Saiki,et al.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.

[52]  D. Teplow,et al.  Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin , 1988, Nature.

[53]  B. Seed An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2 , 1987, Nature.

[54]  H. Ohto,et al.  A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. , 1985, Blood.

[55]  P. D. de Groot,et al.  Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. , 1985, The Journal of biological chemistry.

[56]  Jones Ta,et al.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. , 1985, Methods in enzymology.